Study: Aspirin may help treat a “ferocious form” of breast cancer

A new scientific study said that aspirin tablets may help treat one of the most aggressive types of breast cancer.

According to the British "BBC" network, the study team affiliated with the "Christie Foundation" of the "British National Medical Services" tested aspirin with a number of mice with "triple negative breast cancer", which is the most aggressive type of breast cancer. It does not respond to hormonal or immune therapies due to its lack of receptors that some other breast cancers have and that the treatments target.

The researchers gave the mice the necessary immunological and hormonal treatments along with aspirin, and they said the results were encouraging, and that aspirin's anti-inflammatory properties prompted the tumors to respond to the drugs.

The team is currently working on conducting their experiment on a number of human patients, where they will be given aspirin in addition to the immunotherapy drug avelumab before they receive surgical treatment and chemotherapy.

Dr. Anne Armstrong, who is involved in this study, said that the idea for the experiment came to them after examining previous studies and experiments that revealed the effectiveness of aspirin in preventing the incidence of some types of cancer and reducing the risk of its spread.

“Using a drug like aspirin to treat cancer is exciting,” she said.

Because it is widely available, and it is inexpensive to produce.”

Co-author Dr. Rebecca Lee said: "We hope that aspirin can reduce bad inflammation so that the immune system can continue the task of eliminating cancer cells."

However, the researchers said it was too early to recommend starting aspirin therapy in breast cancer treatments.

As there is a need for more research in this matter.